Group items tagged

In a relief to mining barons Reddy brothers, the Supreme Court Monday permitted them to resume their mining activities in the undisputed area in Andhra Pradesh's Obulapuram.

DR REDDY LABORATORIES- DR REDDY has consolidated with negative biasness in today's trading session, currently facing major resistance at the level of 1619 above which it is likely to take an upward move. It is having support at the level of 1570 below which it may show a downside movement. One can wait to enter into any position as it may give either side of the movement in the forth coming sessions...... Get sure shot tips from here- http://tinyurl.com/7joymsv

Dr Reddy's Laboratories Ltd Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Duration = 3 months Target Price = 4750 INR RecommendationPrice = 4150 - 4200 INR Click on the link to open your Demat account and start trading

Dr. Reddy's Laboratories Limited Stock Analysis | Target Price | RecommendationPrice

The central government plans to fund 28 more cities under the Jawaharlal Nehru National Urban Renewal Mission (JNNURM) during the 12th Five Year Plan (2012-17) to improve civic infrastructure, union Urban Development Minister S. Jaipal Reddy said in Bangalore on Tuesday.

Dr.Reddys, ICICI Bank, Bharat Petroleum Corp, Titan and Cipla were the top gainers in the Nifty while Infosys, Tata Motors, Bajaj Finserve and Bharti Airtel and HCL Tech were top laggards.

The Indian pharma and research firm Dr Reddy's Laboratories announced the launch of generic Paricalcitol injection in the US for treatment associated with chronic kidney disease. In a filing with BSE, the company announced the launch of two injections in the 2mcg, 5mcg, and 10mcg range.

You should buy yelp reviews. Because, In case of any online business people first check the feedback of other about the business.